Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc.

(TSX-V:ODV),(NYSE:ODV), TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development“) announces that, on December 18, 2025, Osisko Development acquired, indirectly through its wholly-owned subsidiary, Barkerville Gold Mines Ltd. (“BGM“), 8,571,429 units of Niobay Metals Inc. (“Niobay“) at a price of $0.14 per unit for an aggregate subscription price […]

Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc.

Osisko Development and Electric Elements File Early Warning Report for Niobay Metals Inc. GlobeNewswire December 23, 2025 TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development“) announces that, on December 18, 2025, Osisko Development acquired, indirectly through its wholly-owned subsidiary, Barkerville Gold Mines Ltd. (“BGM“), 8,571,429 units of

Best BPC-157 Oral Supplements: ProHealth’s Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026

CARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) — This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. This article is for informational purposes only and does not constitute medical

Best BPC-157 Oral Supplements: ProHealth’s Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026

Best BPC-157 Oral Supplements: ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026 36-Year Company's Oral Capsule Format vs. Injectable BPC-157: Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status Examined GlobeNewswire December 23, 2025 CARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) — This article contains affiliate links. If you purchase through

Ongoing Rezolute, Inc. (RZLT) Investigation: Protect Your Rights – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation into Rezolute, Inc. ("Rezolute, Inc.") (NASDAQ:RZLT) concerning potential violations of the federal securities laws. On December 11, 2025, before the market opened, Rezolute announced topline results from its Phase 3 sunRIZE study evaluating

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fermi Inc. – FRMI

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fermi Inc. ("Fermi" or the "Company") (NASDAQ:FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fermi and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of – GALT

NEW YORK CITY, NY / ACCESS Newswire / December 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. ("Galectin" or the "Company") (NASDAQ:GALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galectin and certain of its officers and/or

Scroll to Top